Newsletter | July 21, 2020

07.21.20 -- FDA Grants Priority Review To Merck's New Drug Application For Vericiguat

 
Sponsor
Industry Insights
Lipid-Based Formulations For Early-Stage Clinical Trials

For certain molecules, the most appropriate technology for bioavailability enhancement and accelerated development will be lipid-based formulations (LBF), supported by in silico development tools. Senior Formulation and Product Development Scientists analyze the potential benefits and applications of lipid/liquid-based formulations and how they may reduce timelines to clinical trials.

Create Brand Sustainability With Softgel Technology

Keeping an eye on some emerging trends that are shaping society and the pharmaceutical industry can help you meet diverse consumer preferences and potentially extend product lifecycles.

Western Blot Detection: Is Film Or A Digital CCD Imager Better?

Learn the benefits and drawbacks of using film or a CCD imager to detect the bound antibody in Western blotting, also known as immunoblotting.

First-In-Human Trials: A Make-Or-Break Milestone For Small Biopharmas

Whether biopharmaceutical companies have one candidate or 100, the directive is clear: moving quickly into FIH testing is essential. But, how?

Tumor Infiltrating Lymphocytes As Cell Therapies

As we’ve begun to understand the complexities of immune mechanisms through technology, we’ve found better ways to fight disease. Here, we focus on an important player in such targeted, highly personalized cancer therapies called tumor-infiltrating lymphocytes (TILs).

Meet Aggressive Timelines By Simplifying Your Drug Delivery Supply Chain

To meet an aggressive timeline with a lack of resources, Kaleido Biosciences had to consider an alternative yet efficient route for drug substance, drug product, and clinical trial packaging needs.

Most Popular News
Solutions
Life Science Leader Magazine
 

Have you heard of Life Science Leader?
Check it out today for access to candid interviews with top-tier executives on how they do business.